3 Cups of Coffee a Day: Is It Healthy?

0shared

Many studies confirm that drinking coffee daily (in moderation, of course) is beneficial for your health. For years, people have avoided coffee in the belief that its caffeine content was harmful to the body. However, year after year, new research continues to confirm that drinking coffee is actually good for you.

A few studies have indicated thatcoffee has positive effects in the treatment and prevention of health problems like diabetes, Alzheimer’s and Parkinson’s. New studies are revealing more and more benefits and great reasons to drink coffee. A study conducted by the National Cancer Institute of Bethesda (Maryland, US) and published in Hepatology states that drinking coffee has positive effects on the liver.

To conduct their research, scientists used data from the United States National Health and Nutrition Examination Survey (NHANES 1999-2010) and selected 27,793 participants age 20 or older. Volunteers filled out a survey about their coffee drinking habits and researchers tested their blood, measuring different markers for liver function. The purpose of this study was to measure the health of participants’ livers and it was found that those who drank three or more cups of coffee a day had lower liver enzyme levels compared to non-coffee drinkers.

Researchers found that other compounds in coffee, besides caffeine, promote liver health when consumed in moderation.

Reduce Your Risk of Fatty Liver and Fibrosis with Coffee

Another study, also published in Hepatology, showed that drinking coffee significantly reduces the risk of accumulating connective tissue in the liver (fibrosis) in patients suffering from non-alcoholic fatty liver disease.

The study determined that the caffeine in coffee can reduce the accumulation of connective tissue in those suffering from chronic liver diseases, like fibrosis.

To conduct their study, researchers interviewed 306 people about their caffeine consumption and divided them into groups: patients without signs of fibrosis on ultrasound (the control group), those with steatosis, those with non-alcoholic steatohepatitis (NASH) stages 0-1 and 2-4.

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners.OKSee details